pyrroles has been researched along with Facial Dermatoses in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McKesey, J; Pandya, AG | 1 |
| Dubertret, L; Gressier, L; Pruvost-Balland, C; Viguier, M | 1 |
| Budak, K; Pestalozzi, B; Weisshaupt, Ch | 1 |
3 other study(ies) available for pyrroles and Facial Dermatoses
| Article | Year |
|---|---|
A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo.
Topics: Administration, Cutaneous; Adult; Combined Modality Therapy; Facial Dermatoses; Female; Humans; Male; Pilot Projects; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Severity of Illness Index; Skin Cream; Ultraviolet Therapy; Vitiligo | 2019 |
[Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)].
Topics: Abdominal Pain; Arthralgia; Atorvastatin; Diarrhea; Drug Eruptions; Eosinophilia; Facial Dermatoses; Female; Fever; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Pyrroles | 2009 |
[Adverse effects of new oncologic therapies].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Cetuximab; Colonic Neoplasms; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Everolimus; Facial Dermatoses; Humans; Indoles; Liver Neoplasms; Male; Middle Aged; Neoplasms; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Quinazolines; Sirolimus; Sorafenib; Sunitinib; Trastuzumab | 2011 |